Furthermore, when continuous mRNA expression values were used in the logistic regression model with adjustment for all covariates, there were also dose-response relationships between the reduced mRNA expression levels and the increased HNSCC risks for XPB and XPA (Ptrend < 0.001 and =0.024, respectively, Table 6). The gene discussed is XPA; the disease is head and neck squamous cell carcinoma.